Bitolterol mesylate in exercise-induced asthma. 1986

S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo

Exercise-induced asthma is a useful model for evaluating the activity and duration of action of pharmacologic agents of asthma. The main objective of this double-blind, crossover study was to determine the effect of the aerosolized beta-adrenergic agent, bitolterol mesylate, on exercise-induced asthma while its efficacy was being compared with isoproterenol and placebo. Twelve subjects with exercise-induced asthma performed cycloergometer exercise 45 minutes after three inhalations of bitolterol mesylate aerosol (1050 micrograms), or isoproterenol (255 micrograms), or placebo in random sequence. Bitolterol mesylate aerosol was very effective in protecting against exercise-induced asthma. The mean percent maximal decrease of FEV1 after exercise was 5.0% for bitolterol, 22.2% for isoproterenol, and 23.2% for placebo. Subjects experienced skeletal muscle tremor with both bitolterol mesylate (four subjects) and isoproterenol (three subjects), but not with placebo. No other side effects were noted.

UI MeSH Term Description Entries
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D008297 Male Males
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D004983 Ethanolamines AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives. Aminoethanols
D005260 Female Females
D005541 Forced Expiratory Volume Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity. Forced Vital Capacity, Timed,Timed Vital Capacity,Vital Capacity, Timed,FEVt,Capacities, Timed Vital,Capacity, Timed Vital,Expiratory Volume, Forced,Expiratory Volumes, Forced,Forced Expiratory Volumes,Timed Vital Capacities,Vital Capacities, Timed,Volume, Forced Expiratory,Volumes, Forced Expiratory
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol

Related Publications

S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
March 1994, Annals of allergy,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
January 1984, The Journal of allergy and clinical immunology,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
June 1986, Annals of allergy,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
January 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
July 1987, Annals of allergy,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
May 1987, The Journal of allergy and clinical immunology,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
March 1986, The Journal of allergy and clinical immunology,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
April 1987, Chest,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
January 1995, Advances in therapy,
S B Walker, and C W Bierman, and W E Pierson, and G G Shapiro, and C T Furukawa, and T S Mingo
February 1989, The American review of respiratory disease,
Copied contents to your clipboard!